Skip to main content

Tenon Medical, Inc.

corporate_fare Company Profile

Tenon Medical, Inc.

TNON·NASDAQ·Industrial Applications And Services·CIK 0001560293

Tenon Medical, Inc. is a medical device company focused on improving care for patients with specific sacro-pelvic disorders. Incorporated in Delaware on June 19, 2012, the company was headquartered in San Ramon, California until June 2021, when it moved to Los Gatos, California. Tenon Medical currently provides two systems for treating a diseased sacroiliac joint (SI Joint). The Catamaran®™ SI Joint Fusion System, which received U.S. Food and Drug Administration (FDA) clearance in 2018, offers a less invasive approach to the SI Joint using a single, robust, titanium implant for common SI Joint disorders causing lower back pain. Since its national launch in October 2022, the company has concentrated on the US market and three commercial opportunities: primary SI Joint procedures, revision procedures for failed SI Joint implants, and SI Joint fusion as an adjunct to a spine fusion construct. In August 2025, Tenon Medical acquired substantially all assets of SiVantage, Inc. and SIMPL Medical, LLC, including The SImmetry +® SI Joint Fusion System. This system treats SI Joint disorders through a minimally invasive lateral access solution, incorporating orthopedic fusion principles such as joint decortication, bone graft placement, and rigid fixation to achieve biological fusion across the SI Joint.

Tenon Medical, Inc. (NASDAQ:TNON) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 42 items for TNON at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Tenon Medical Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price
  • Tenon Medical Reports Strong Preliminary Q4 and Full Year 2025 Revenue Growth

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
3.94M
Net Income
-12.56M
Diluted EPS
-1.70
Op. Cash Flow
-10.74M
Free Cash Flow
-11.02M
Gross Profit
2.36M
Operating Income
-12.79M
Cash & Equivalents
3.76M
Debt / Equity
0.00×
Net Margin
-318.4%
Shares Outstanding
10.85M sh
Source: 10-K · filed 2026-03-27 · accession 0001213900-26-035707
$5.44 -0.49% today
52-week range · as of 2026-09-09 $3.18 – $50.4
Market cap
$6.12M
Volume
108.6M (10.1× avg)
3-mo avg 10.8M
Live data · 2026-09-14 00:57 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TNON - Filings & News (Page 3)

TNON
Feb 27, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8651
Real-time Price: $5.44 info
Change: Reverse Stock Split info
Market Cap: $6.123M info
TNON
Feb 06, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6712
Real-time Price: $5.44 info
Change: Reverse Stock Split info
Market Cap: $6.123M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets